Combined miR-486 and GP88 (Progranulin) Serum Levels Are Suggested as Supportive Biomarkers for Therapy Decision in Elderly Prostate Cancer Patients

Alexander Fichte, Verena Lieb, Katrin Weigelt et al.|Life|2022

Cited by 3